Avita Medical Inc (RCEL)

Stock price, financials, and technical signals for Avita Medical Inc (RCEL).

$8.61

-0.09

(-1.03%)

As of 02/12/2025 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

RCEL Performance Snapshot


1-Week Chg

-8.79%

1-Month Chg

-5.80%

3-Month Chg

-31.99%

6-Month Chg

-10.13%

1-Year Chg

-50.74%

Year-To-Date Chg

-32.68%

Beta 1-Year

2.36

Beta 5-Year

1.59

Volatility (10-Day)

3.28%

RCEL Technicals



Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-02-12

$8.61

-$0.09 (-1.03%)

$8.61

$8.73

$8.37

$8.57

139.96K ($1.21M)

2025-02-11

$8.70

-$0.10 (-1.14%)

$8.72

$9

$8.66

$8.79

84.78K ($737.62K)

2025-02-10

$8.80

$0.12 (1.38%)

$8.77

$8.99

$8.69

$8.83

139.81K ($1.23M)

2025-02-07

$8.68

-$0.46 (-5.03%)

$9.10

$9.11

$8.64

$8.81

190.13K ($1.65M)

2025-02-06

$9.14

-$0.30 (-3.18%)

$9.40

$9.50

$9.13

$9.26

164.46K ($1.50M)

2025-02-05

$9.44

$0.28 (3.06%)

$9.22

$9.46

$9.04

$9.31

89.25K ($842.57K)

2025-02-04

$9.16

$0.29 (3.27%)

$8.87

$9.18

$8.85

$9.06

62.08K ($568.63K)

2025-02-03

$8.87

-$0.23 (-2.53%)

$8.86

$9.01

$8.71

$8.86

88.65K ($786.35K)

2025-01-31

$9.10

-$0.37 (-3.91%)

$9.44

$9.50

$9.05

$9.22

111.29K ($1.01M)

2025-01-30

$9.47

$0.07 (0.74%)

$9.50

$9.60

$9.42

$9.50

83.23K ($788.16K)

RCEL Financials


Balance Sheet

(USD)

2024 Q3

Y/Y CHANGE


  • Cash and equivalents

    $18.64M

    -63.35%

  • Total assets

    $81.05M

    0.05%

  • Total liabilities

    $68.60M

    294.09%

  • Total investments

    $25.77M

    178.13%

  • Shareholders' equity

    $12.23M

    -80.59%

  • Book value per share

    $0.47

    -81.00%


Income Statement

(USD)

2024 Q3

Y/Y CHANGE


  • Revenue

    $19.55M

    41.06%

  • Net income

    -$16.20M

    -86.01%

  • Operating expense

    $30.16M

    43.29%

  • Gross profit

    $16.36M

    39.27%

  • EBITDA

    -$14.36M

    -72.43%

  • Earnings per share

    -$0.62

    -82.35%


Cash Flow

(USD)

2024 Q3

Y/Y CHANGE


  • Net change in cash

    $1.19M

    -91.12%

  • Cash from operations

    -$7.21M

    19.61%

  • Cash from investing

    $7.39M

    -66.02%

  • Cash from financing

    $1.01M

    67.83%

  • Free cash flow

    -$10.97M

    -15.81%

  • Free cash flow per share

    -$0.42

    -13.14%


Metrics

(USD)

2024 Q3

Y/Y CHANGE


  • Market capitalization

    $278.61M

    -25.15%

  • Enterprise value

    $305.43M

    -9.04%

  • Shares outstanding

    25.99M

    2.01%

  • Profit margin

    -82.90%

    -31.80%

  • Gross margin

    83.70%

    -1.30%

  • EBITDA margin

    -73.50%

    -22.30%


Dividends

(USD)

2024 Q3

Y/Y CHANGE


  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    3.73

    -40.30%


Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.